Both EZH2 and BMI1 have also been implicated in pancreatic cancer stem cell maintenance, a functional subset of tumor cells thought to promote PDA chemoresistance and tumor relapse [64,65]. This evidence concerns the gene EZH2 and Patent ductus arteriosus.